1. Home
  2. PANL vs PVLA Comparison

PANL vs PVLA Comparison

Compare PANL & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pangaea Logistics Solutions Ltd.

PANL

Pangaea Logistics Solutions Ltd.

HOLD

Current Price

$7.19

Market Cap

414.5M

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$97.02

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PANL
PVLA
Founded
1996
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
414.5M
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PANL
PVLA
Price
$7.19
$97.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
16
Target Price
$9.00
$124.25
AVG Volume (30 Days)
325.9K
259.5K
Earning Date
11-06-2025
11-11-2025
Dividend Yield
2.78%
N/A
EPS Growth
N/A
N/A
EPS
0.27
N/A
Revenue
$595,335,937.00
N/A
Revenue This Year
$18.51
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$26.89
N/A
Revenue Growth
14.22
N/A
52 Week Low
$3.93
$11.17
52 Week High
$7.38
$106.71

Technical Indicators

Market Signals
Indicator
PANL
PVLA
Relative Strength Index (RSI) 67.36 59.02
Support Level $7.04 $95.28
Resistance Level $7.38 $100.00
Average True Range (ATR) 0.22 6.07
MACD -0.05 -0.60
Stochastic Oscillator 70.63 42.95

Price Performance

Historical Comparison
PANL
PVLA

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk logistics and transportation services. It transports various drybulk cargoes including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The company provides ocean transportation services to clients utilizing an ocean-going fleet of motor vessels in the Handymax, Supramax, Ultramax, Panamax, and Post-Panamax segments. Its services include cargo loading, cargo discharge, vessel chartering, voyage planning, and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters. Geographically, it derives key revenue from the United States, followed by Canada, Germany, and others.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: